6 research outputs found

    BMS-204352 enhances the KCNQ4 current

    No full text

    Activation of the human intermediate-conductance Ca2+-activated K+ channel by 1-ethyl-2-benzimidazolinone is strongly Ca2+-dependent

    Get PDF
    AbstractModulation of the cloned human intermediate-conductance Ca2+-activated K+ channel (hIK) by the compound 1-ethyl-2-benzimidazolinone (EBIO) was studied by patch-clamp technique using human embryonic kidney cells (HEK 293) stably expressing the hIK channels. In whole-cell studies, intracellular concentrations of free Ca2+ were systematically varied, by buffering the pipette solutions. In voltage-clamp, the hIK specific currents increased gradually from 0 to ≈300 pA/pF without reaching saturation even at the highest Ca2+ concentration tested (300 nM). In the presence of EBIO (100 μM), the Ca2+-activation curve was shifted leftwards, and maximal currents were attained at 100 nM Ca2+. In current-clamp, steeply Ca2+-dependent membrane potentials were recorded and the cells gradually hyperpolarised from −20 to −85 mV when Ca2+ was augmented from 0 to 300 nM. EBIO strongly hyperpolarised cells buffered at intermediate Ca2+ concentrations. In contrast, no effects were detected either below 10 nM (no basic channel activation) or at 300 nM Ca2+ (Vm close to EK). Without Ca2+, EBIO-induced hyperpolarisations were not obtainable, indicating an obligatory Ca2+-dependent mechanism of action. When applied to inside-out patches, EBIO exerted a Ca2+-dependent increase in the single-channel open-state probability, showing that the compound modulates hIK channels by a direct action on the α-subunit or on a closely associated protein. In conclusion, EBIO activates hIK channels in whole-cell and inside-out patches by a direct mechanism, which requires the presence of internal Ca2+
    corecore